A grant from the U.S. Department of State will create a clinical telehealth program in Botswana in partnership with Rutgers, the University of Botswana, and Botswana’s Ministry of Health and Wellness.
Vaccine access amid political turmoil in Venezuela is the backdrop of institute director Richard Marlink’s comments, for a story published by Devex, about COVAX and a global response to the pandemic.
Three student teams were named winners of the first-ever Global Health Case Competition, a 10-week experience focused on the impact of COVID-19 on underserved communities in New Jersey.
On Rutgers Giving Day, a 24-hour fundraising event, Rutgers Global Health Institute raised $18,870 to help confront health disparities in New Jersey.
It’s been a year since COVID-19 was declared a global pandemic. Rutgers Global Health Institute core faculty members discuss the health crisis in relation to their own areas of expertise and professional practice.
In an interview with The Daily Targum, institute director Richard Marlink explains the international collaboration to distribute COVID-19 vaccines more equitably worldwide.
Rutgers Global Health Institute Launches Program to Help Small Businesses Impacted by the COVID-19 Pandemic
The three-part program provides guidance on safe operations and related support services for small businesses and nonprofits in New Jersey’s low-income and minority communities.
Following the FDA’s emergency approval of Johnson & Johnson’s COVID-19 vaccine, ROI-NJ published a collection of health experts’ perspectives that includes institute director Richard Marlink’s comments about vaccine efficacy.
The dashboard, which displays information to help state residents, stakeholders, and policy makers understand the range of services available to youth and families, comes at a critical time. The pandemic continues to impact children and youth, who face increased levels of anxiety, stress, isolation, and a sense of loss and grief.
In an interview for WRSU Rutgers Radio, institute director Richard Marlink offers perspective on the importance of a global response to COVID-19, vaccine infrastructure in Africa, vaccine production and safety, and the World Health Organization.